Clearwater Capital Advisors’s Biogen BIIB Stock Holding History

Clearwater Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-213	Closed	-$58K	–	220
2018 Q1	$58K	Buy	+213	New	+$66.1K	0.01%	283

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clearwater Capital Advisors's BIIB Position: Q2 2018 in Review

Clearwater Capital Advisors sold out of Biogen (BIIB) in Q2 2018, closing a stake of 213 shares — an estimated $58K sold.

Clearwater Capital Advisors first reported a position in BIIB in Q1 2018 and held it in 1 quarter. The position peaked at $58K in Q1 2018. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

Clearwater Capital Advisors reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
Clearwater Capital Advisors sold 213 Biogen shares in Q2 2018, an estimated $58K.
Clearwater Capital Advisors first reported a position in Biogen in Q1 2018 and held it in 1 quarter.
Clearwater Capital Advisors's Biogen position peaked at $58K in Q1 2018.
1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Clearwater Capital Advisors's 13F filing for Q2 2018, filed 16 Aug 2018.